Increased mutagen-induced chromosome damage in patients with transformed laryngeal pre-cancerosis

International Journal of Cancer

Volumn 68, Issue 6, 1996, Pages 700-703

  Gallo, Oreste ^a   Santoro, Roberto ^a   Lenzi, Silvia ^a   Boddi, Vieri ^a   Giovannucci Uzielli, Maria Luisa ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BLEOMYCIN;

ADULT; AGED; ARTICLE; CANCER RISK; CHROMOSOME ABERRATION; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; LARYNX CANCER; MALE; PRECANCER; PRIORITY JOURNAL; TUMOR GROWTH;

ADULT; AGED; BLEOMYCIN; CASE-CONTROL STUDIES; CELL TRANSFORMATION, NEOPLASTIC; CHROMOSOME ABERRATIONS; CYTOGENETICS; FEMALE; HUMANS; LARYNGEAL DISEASES; LARYNGEAL NEOPLASMS; LYMPHOCYTES; MALE; MIDDLE AGED; MUTAGENS; PRECANCEROUS CONDITIONS; SMOKING;

EID: 0030512082     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19961211)68:6<700::AID-IJC2>3.0.CO;2-7     Document Type: Article

References (25)

1. BLACKWELL, K.E., FU, Y. and CALCATERRA, T.C., Laryngeal dysplasia. A clinicopathological study. Cancer, 75, 457-463 (1995).
2. BOUQUOT, J.E., Epidemiology. In: D. R. Gnepp (ed.), Pathology of the head and neck, pp. 263-314, Churchill-Livingstone, New York (1988).
3. BOUQUOT, J.E. and GNEPP, D.O., Laryngeal pre-cancer: a review of the literature, commentary, and comparison with oral leukoplakia. Head Neck, 13, 488-497 (1991).
4. CLOOS, J., SPITZ, M.R., SCHANTZ, S.P., HSU, T.C., ZHANG, Z., TOBI, H., BRAAKHUIS, B.J.M. and SNOWN, G.B., Genetic susceptibility to head-and-neck squamous-cell carcinoma. J. Nat. Cancer Inst., 88, 530-535 (1996).
5. CUCHI, A., BOMBI, J.A., AVELLANEDA, R., CARDESA, A. and TRASERRA, J., Pre-cancerous lesions of the larynx: clinical and pathologic correlations and prognostic aspects. Head Neck, 16, 545-549 (1994).
6. DAVIDSON, B.J., HSU, T.C. and SCHANTZ, S.P., The genetics of tobacco-induced malignancy. Arch. Otolaryngol. Head Neck Surg., 119, 1198-1205 (1993).
7. DOLCETTI, R., DOGLIONI, C., MAESTRO, R., GASPAROTTO, D., BARZAN, L., PASTORE, A., ROMANELLI, M. and BAIOCCHI, M., p53 over-expression is an early event in the development of human squamous-cell carcinoma of the larynx: genetic and prognostic implications. Int. J. Cancer, 52, 178-182 (1992).
8. FOURET, P., DABIT, D., SIBONY, M., ALILI, D., COMMO, F., SAINY-GUILY, J.L. and CALLARD, P., Expression of p53 protein related to the presence of human-papillomavirus infection in pre-cancer lesions of the larynx. Amer. J. Pathol, 146, 599-604 (1995).
9. GALLO, O., BIANCHI, S., GIANNINI, A., BOCCUZZI, S., CALZOLARI, A. and FINI-STORCHI, O., Lack of detection of human papillomavirus (HPV) in transformed laryngeal keratoses by in situ hybridization (ISH) technique. Acta oto-laryngol. (Stockh.), 114, 213-217 (1994).
10. GALLO, O., BIANCHI, S., GIOVANNUCCI-UZIELLI, M.L., SANTORO, R., LENZI, S., SALIMBENI, C., ABBRUZZESE, M. and ALAJMO, E., p53 oncoprotein over-expression correlates with mutagen-induced chromosome fragility in head-and-neck-cancer patients with multiple malignancies. Brit. J. Cancer, 71, 1008-1012 (1995).
11. HONG, W.K., LIPPMAN, S.M., HITTELMAN, W.N. and LOTAN, R., Retinoid in the chemoprevention of aerodigestive cancer: from basic research to the clinic. Clin. Cancer Res., 1, 677-686 (1995).
12. HSU, T.C., JOHNSTON, D.A., CHERRY, L.M., RAMILKKSON, D., SCHANTZ, S.P., JESSUP, J.M., WINN, R.J., SHIRLEY, L. and FURLONG, C., Sensitivity to genotoxic effects of bleomycin in humans: possible relationship to environmental carcinogenesis. Int. J. Cancer, 43, 403-409 (1989).
13. LIPPMAN, S.M., BENNER, S.E. and HONG, W.K., Cancer chemoprevention. J. clin. Oncol., 12, 851-873 (1994).
14. MUNCK-WUKLAND, E., EDSTROM, S., JUNGMARK, E., KULYIENSTERNA, R., LINDHOLMI, J. and AUER, G., Nuclear DNA content, proliferating nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions. Int. J. Cancer, 56, 95-99 (1994).
15. 2-phase X-irradiation of cells from cancer-prone individuals implicates deficiency in DNA repair. Proc. Nat. Acad. Sci. (Wash.), 80, 5612-5616 (1993).
16. PIERCE, N.H., Leukoplakia laryngis. Ann. Otol. Rhinol. Laryngol., 77, 33-56 (1920).
17. SCHANTZ, S.P. and Hsu, T.C., Mutagen-induced chromosome fragility within peripheral-blood lymphocytes of head-and-neck-cancer patients. Head Neck, 11, 337-342 (1989).
18. SCHANTZ, S.P., HSU, T.C., AINSLI, N. and MOSER, R.P., Young adults with head-and-neck cancer express increased susceptibility to mutageninduced chromosome damage. J. Amer. med. Ass., 262, 3313-3315 (1989).
19. SCHANTZ, S.P., SPITZ, M.R. and HSU, T.C., Mutagen sensitivity in patients with head-and-neck cancers: a biologic marker for risk of multiple primary malignancies. J. Nat. Cancer Inst., 82, 1773-1775 (1990).
20. SCHOTTENFELD, D. and BERG, J.W., Epidemiology of multiple primary cancers. In: D. Schottenfeld (ed.), Cancer epidemiology and prevention: current concepts, pp. 416-434, W.B. Saunders, Springfield, IL (1975).
21. SHIN, D.M., KIM, J., RO, Y.J., HITTELMAN, J., ROTH, J.A., HONG, W.K. and HITTELMAN, W.N., Activation of p53 gene expression in premalignant lesions during head-and-neck tumorigenesis. Cancer Res., 54, 321-326 (1994).
22. SPITZ, M.R., Epidemiology and risk factors for head-and-neck cancer. Semin. Oncol, 21, 281-288 (1994).
23. SPITZ, M.R., FUEGER, J.J., BEDDINGFIELD, N.A., ANNENGERS, J.F., HSU, T.C., NEWELL, G.R. and SCHANTZ, S.P., Chromosome sensitivity to bleomycin-induced mutagenesis, an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49, 4626-4628 (1989).
24. VOKES, E.E., WEICHSELBAUM, R.R., LIPPMAN, S.M. and HONG, W.K., Head-and-neck cancer. New Engl. J. Med., 328, 184-194 (1993).
25. WEINSTEIN, I.B., The origin of human cancer: molecular mechanisms of carcinogenesis and their implications for cancer prevention and treatment. Twenty-seventh G.H.A. Clowes Memorial Award Lecture. Cancer Res., 48, 4135-4143 (1988).